Company decision to pull diabetes drug could add GBP9 million to NHS drugs bill
Tuesday, August 3, 2010 - 18:21
in Health & Medicine
Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add GBP9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB).